Latest Insider Transactions at Bridge Bio Pharma, Inc. (BBIO)
This section provides a real-time view of insider transactions for Bridge Bio Pharma, Inc. (BBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BridgeBio Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BridgeBio Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2020
|
Charles J Homcy |
SELL
Open market or private sale
|
Direct |
10,000
-0.82%
|
$380,000
$38.0 P/Share
|
|
Sep 30
2020
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.82%
|
$170,000
$17.0 P/Share
|
|
Jun 27
2019
|
Viking Global Investors LP |
BUY
Open market or private purchase
|
Indirect |
4,705,900
+15.02%
|
$80,000,300
$17.0 P/Share
|
|
Jun 27
2019
|
Viking Global Investors LP |
BUY
Conversion of derivative security
|
Indirect |
21,915,091
+40.86%
|
-
|